{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T02:25:54Z","timestamp":1648866354961},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1756-0500-7-646","type":"journal-article","created":{"date-parts":[[2014,9,13]],"date-time":"2014-09-13T13:01:02Z","timestamp":1410613262000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Expression level of dihydropyrimidine dehydrogenase is associated with clinical outcome in patients with T1G3 bladder cancer treated with Bacillus Calmette-Guerin"],"prefix":"10.1186","volume":"7","author":[{"given":"Hiroki","family":"Ide","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuji","family":"Mikami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Miyajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mototsugu","family":"Oya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,9,13]]},"reference":[{"issue":"3","key":"3165_CR1","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1002\/1097-0142(20010801)92:3<510::AID-CNCR1349>3.0.CO;2-0","volume":"92","author":"Y Mizutani","year":"2001","unstructured":"Mizutani Y, Wada H, Ogawa O, Yoshida O, Fukushima M, Nonomura N, Miki T: Prognostic significance of thymidylate synthase activity in bladder carcinoma. Cancer. 2001, 92 (3): 510-518. 10.1002\/1097-0142(20010801)92:3<510::AID-CNCR1349>3.0.CO;2-0.","journal-title":"Cancer"},{"issue":"5","key":"3165_CR2","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S0959-8049(00)00440-8","volume":"37","author":"Y Mizutani","year":"2001","unstructured":"Mizutani Y, Wada H, Fukushima M, Yoshida O, Ukimura O, Kawauchi A, Miki T: The significance of dihydropyrimidine dehydrogenase (DPD) activity in bladder cancer. Eur J Cancer. 2001, 37 (5): 569-575. 10.1016\/S0959-8049(00)00440-8.","journal-title":"Eur J Cancer"},{"issue":"4","key":"3165_CR3","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/cncr.11955","volume":"100","author":"Y Mizutani","year":"2004","unstructured":"Mizutani Y, Wada H, Fukushima M, Yoshida O, Nakanishi H, Li YN, Miki T: Prognostic significance of orotate phosphoribosyltransferase activity in bladder carcinoma. Cancer. 2004, 100 (4): 723-731. 10.1002\/cncr.11955.","journal-title":"Cancer"},{"issue":"2","key":"3165_CR4","first-page":"289","volume":"9","author":"Y Mizutani","year":"2002","unstructured":"Mizutani Y, Wada H, Yoshida O, Fukushima M, Bonavida B, Kawauchi A, Miki T: Prognostic significance of a combination of thymidylate synthase and dihydropyrimidine dehydrogenase activities in grades 1 and 2 superficial bladder cancer. Oncol Rep. 2002, 9 (2): 289-292.","journal-title":"Oncol Rep"},{"issue":"5","key":"3165_CR5","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1002\/1097-0142(19930301)71:5<1842::AID-CNCR2820710520>3.0.CO;2-2","volume":"71","author":"Y Kubota","year":"1993","unstructured":"Kubota Y, Hosaka M, Fukushima S, Kondo I: Prophylactic oral UFT therapy for superficial bladder cancer. Cancer. 1993, 71 (5): 1842-1845. 10.1002\/1097-0142(19930301)71:5<1842::AID-CNCR2820710520>3.0.CO;2-2.","journal-title":"Cancer"},{"key":"3165_CR6","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1186\/1471-2407-12-420","volume":"12","author":"H Ide","year":"2012","unstructured":"Ide H, Kikuchi E, Hasegawa M, Kozakai N, Kosaka T, Miyajima A, Oya M: Prognostic significance of 5-fluorouracil metabolism-relating enzymes and enhanced chemosensitivity to 5-fluorouracil by 5-chloro 2,4-dihydroxy-pyridine in urothelial carcinoma. BMC Cancer. 2012, 12: 420-10.1186\/1471-2407-12-420.","journal-title":"BMC Cancer"},{"issue":"2","key":"3165_CR7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1053\/j.seminoncol.2006.12.013","volume":"34","author":"M Sanchez-Carbayo","year":"2007","unstructured":"Sanchez-Carbayo M, Cordon-Cardo C: Molecular alterations associated with bladder cancer progression. Semin Oncol. 2007, 34 (2): 75-84. 10.1053\/j.seminoncol.2006.12.013.","journal-title":"Semin Oncol"},{"issue":"1","key":"3165_CR8","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/j.1442-2042.2011.02856.x","volume":"19","author":"H Azuma","year":"2012","unstructured":"Azuma H, Inamoto T, Takahara K, Ibuki N, Nomi H, Yamamoto K, Narumi Y, Ubai T: Neoadjuvant and adjuvant chemotherapy for locally advanced bladder carcinoma: development of novel bladder preservation approach, Osaka Medical College regimen. Int J Urol. 2012, 19 (1): 26-38. 10.1111\/j.1442-2042.2011.02856.x.","journal-title":"Int J Urol"},{"issue":"5","key":"3165_CR9","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/j.1442-2042.2012.02974.x","volume":"19","author":"F Koga","year":"2012","unstructured":"Koga F, Kihara K: Selective bladder preservation with curative intent for muscle-invasive bladder cancer: a contemporary review. Int J Urol. 2012, 19 (5): 388-401. 10.1111\/j.1442-2042.2012.02974.x.","journal-title":"Int J Urol"},{"issue":"4","key":"3165_CR10","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1111\/j.1442-2042.2012.03148.x","volume":"20","author":"G Simone","year":"2013","unstructured":"Simone G, Papalia R, Ferriero M, Guaglianone S, Castelli E, Collura D, Muto G, Gallucci M: Stage-specific impact of extended versus standard pelvic lymph node dissection in radical cystectomy. Int J Urol. 2013, 20 (4): 390-397. 10.1111\/j.1442-2042.2012.03148.x.","journal-title":"Int J Urol"},{"issue":"Suppl 1","key":"3165_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000052376","volume":"37","author":"DL Lamm","year":"2000","unstructured":"Lamm DL: Preventing progression and improving survival with BCG maintenance. Eur Urol. 2000, 37 (Suppl 1): 9-15.","journal-title":"Eur Urol"},{"issue":"6","key":"3165_CR12","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0302-2838(02)00173-2","volume":"41","author":"JJ Patard","year":"2002","unstructured":"Patard JJ, Rodriguez A, Leray E, Rioux-Leclercq N, Guille F, Lobel B: Intravesical Bacillus Calmette-Guerin treatment improves patient survival in T1G3 bladder tumours. Eur Urol. 2002, 41 (6): 635-641. 10.1016\/S0302-2838(02)00173-2. discussion 642","journal-title":"Eur Urol"},{"issue":"1","key":"3165_CR13","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1097\/01.ju.0000132129.87598.3b","volume":"172","author":"GN Thalmann","year":"2004","unstructured":"Thalmann GN, Markwalder R, Shahin O, Burkhard FC, Hochreiter WW, Studer UE: Primary T1G3 bladder cancer: organ preserving approach or immediate cystectomy?. J Urol. 2004, 172 (1): 70-75. 10.1097\/01.ju.0000132129.87598.3b.","journal-title":"J Urol"},{"key":"3165_CR14","first-page":"177","volume":"15","author":"T Horikoshi","year":"1993","unstructured":"Horikoshi T, Danenberg K, Volkenandt M, Stadlbauer T, Danenberg PV: Quantitative measurement of relative gene expression in human tumors. Methods Mol Biol. 1993, 15: 177-188.","journal-title":"Methods Mol Biol"},{"issue":"6","key":"3165_CR15","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1002\/ijc.20511","volume":"112","author":"W Ichikawa","year":"2004","unstructured":"Ichikawa W, Takahashi T, Suto K, Nihei Z, Shirota Y, Shimizu M, Sasaki Y, Hirayama R: Thymidylate synthase and dihydropyrimidine dehydrogenase gene expression in relation to differentiation of gastric cancer. Int J Cancer. 2004, 112 (6): 967-973. 10.1002\/ijc.20511.","journal-title":"Int J Cancer"},{"issue":"5289","key":"3165_CR16","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1126\/science.274.5289.998","volume":"274","author":"MR Emmert-Buck","year":"1996","unstructured":"Emmert-Buck MR, Bonner RF, Smith PD, Chuaqui RF, Zhuang Z, Goldstein SR, Weiss RA, Liotta LA: Laser capture microdissection. Science. 1996, 274 (5289): 998-1001. 10.1126\/science.274.5289.998.","journal-title":"Science"},{"issue":"12","key":"3165_CR17","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1097\/00000478-199812000-00001","volume":"22","author":"JI Epstein","year":"1998","unstructured":"Epstein JI, Amin MB, Reuter VR, Mostofi FK: The World Health Organization\/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol. 1998, 22 (12): 1435-1448. 10.1097\/00000478-199812000-00001.","journal-title":"Am J Surg Pathol"},{"issue":"5342","key":"3165_CR18","doi-asserted-by":"publisher","first-page":"1481,1483","DOI":"10.1126\/science.278.5342.1481","volume":"278","author":"RF Bonner","year":"1997","unstructured":"Bonner RF, Emmert-Buck M, Cole K, Pohida T, Chuaqui R, Goldstein S, Liotta LA: Laser capture microdissection: molecular analysis of tissue. Science. 1997, 278 (5342): 1481,1483-","journal-title":"Science"},{"issue":"2","key":"3165_CR19","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S1091-255X(00)80049-9","volume":"4","author":"RV Lord","year":"2000","unstructured":"Lord RV, Salonga D, Danenberg KD, Peters JH, DeMeester TR, Park JM, Johansson J, Skinner KA, Chandrasoma P, DeMeester SR, Bremner CG, Tsai PI, Danenberg PV: Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, adenocarcinoma sequence. J Gastrointest Surg. 2000, 4 (2): 135-142. 10.1016\/S1091-255X(00)80049-9.","journal-title":"J Gastrointest Surg"},{"issue":"3","key":"3165_CR20","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/sj.bjc.6600768","volume":"88","author":"J Atzpodien","year":"2003","unstructured":"Atzpodien J, Royston P, Wandert T, Reitz M: Metastatic renal carcinoma comprehensive prognostic system. Br J Cancer. 2003, 88 (3): 348-353. 10.1038\/sj.bjc.6600768.","journal-title":"Br J Cancer"},{"issue":"3","key":"3165_CR21","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/S0022-5347(01)63731-5","volume":"159","author":"T Lebret","year":"1998","unstructured":"Lebret T, Becette V, Barbagelatta M, Herve JM, Gaudez F, Barre P, Lugagne PM, Botto H: Correlation between p53 over expression and response to bacillus Calmette-Guerin therapy in a high risk select population of patients with T1G3 bladder cancer. J Urol. 1998, 159 (3): 788-791. 10.1016\/S0022-5347(01)63731-5.","journal-title":"J Urol"},{"issue":"4","key":"3165_CR22","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1016\/j.juro.2010.05.085","volume":"184","author":"M Alvarez-Mugica","year":"2010","unstructured":"Alvarez-Mugica M, Cebrian V, Fernandez-Gomez JM, Fresno F, Escaf S, Sanchez-Carbayo M: Myopodin methylation is associated with clinical outcome in patients with T1G3 bladder cancer. J Urol. 2010, 184 (4): 1507-1513. 10.1016\/j.juro.2010.05.085.","journal-title":"J Urol"},{"issue":"4","key":"3165_CR23","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/j.1464-410X.2008.08099.x","volume":"103","author":"Y Li","year":"2009","unstructured":"Li Y, Li X, Dai H, Sun X, Li J, Yang F, Gu H, Yang Y, Jin Z, Chu Y, Jin X, Kakehi Y, Wu X: Thymidylate synthase was associated with patient prognosis and the response to adjuvant therapy in bladder cancer. BJU Int. 2009, 103 (4): 547-552. 10.1111\/j.1464-410X.2008.08099.x.","journal-title":"BJU Int"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-0500-7-646.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T05:45:55Z","timestamp":1630561555000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/1756-0500-7-646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,13]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["3165"],"URL":"https:\/\/doi.org\/10.1186\/1756-0500-7-646","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,13]]},"assertion":[{"value":"23 July 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"646"}}